HACKETT PATRICK T 4
4 · Outset Medical, Inc. · Filed Mar 11, 2025
Insider Transaction Report
Form 4
HACKETT PATRICK T
Director
Transactions
- Exercise/Conversion
Series A Non-Voting Convertible Preferred
2025-03-10−5,000→ 0 totalExercise: $0.00From: 2025-03-10→ Preferred Stock (5,000 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred
2025-03-10−5,000→ 0 total(indirect: By Trust)Exercise: $0.00From: 2025-03-10→ Preferred Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-03-10+1,250,000→ 1,292,849 total - Award
Series A Non-Voting Convertible Preferred
2025-03-07$200.00/sh+5,000$1,000,000→ 5,000 total(indirect: By Trust)Exercise: $0.00From: 2025-03-10→ Preferred Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2025-03-10+1,250,000→ 1,250,000 total(indirect: By Trust) - Award
Series A Non-Voting Convertible Preferred
2025-03-07$200.00/sh+5,000$1,000,000→ 5,000 totalExercise: $0.00From: 2025-03-10→ Preferred Stock (5,000 underlying) - Exercise/Conversion
Series A Non-Voting Convertible Preferred
2025-03-10−2,500→ 0 total(indirect: Hackett Family Fund)Exercise: $0.00From: 2025-03-10→ Preferred Stock (2,500 underlying) - Exercise/Conversion
Common Stock
2025-03-10+625,000→ 625,000 total(indirect: Hackett Family Fund) - Award
Series A Non-Voting Convertible Preferred
2025-03-07$200.00/sh+2,500$500,000→ 2,500 total(indirect: Hackett Family Fund)Exercise: $0.00From: 2025-03-10→ Preferred Stock (2,500 underlying)
Footnotes (2)
- [F1]The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its Meeting of Stockholders, held on March 5, 2025, after which each share of Preferred Stock automatically converted into 250 shares of Common Stock on March 10, 2025.
- [F2]These shares of Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") were issued to the Reporting Person under securities purchase agreements entered into with the Issuer, pursuant to which the Issuer agreed to submit to its stockholders the approval of the conversion of the Preferred Stock into shares of Common Stock at its March 5, 2025 Meeting of Stockholders (the "Conversion Proposal"). The Issuer's stockholders approved the Conversion Proposal and each share of Preferred Stock will automatically convert into 250 shares of Common Stock, subject to certain limitations. The Preferred Stock has no expiration date.